Enzymatic oxidation of cholesterol generates numerous distinct bile acids which function both as detergents that facilitate the digestion and absorption of dietary lipids and as hormones that activate five distinct receptors. Activation of these receptors alters gene expression in multiple tissues, leading to changes not only in bile acid metabolism but also in glucose homeostasis, lipid and lipoprotein metabolism, energy expenditure, intestinal motility, bacterial growth, inflammation, and in the liver-gut axis. This review focuses on the present knowledge regarding the physiologic and pathologic role of bile acids and their immunomodulatory role, with particular attention to bacterial lipopolysaccharides (endotoxins) and bile acid and immunological disorders. The specific role that bile acids play in the regulation of innate immunity, various systemic inflammations, inflammatory bowel diseases, allergy, psoriasis, cholestasis, obesity, metabolic syndrome, alcoholic liver disease, and colon cancer will be reviewed.

Keywords:
Bile acid, Endotoxin, Immune system, Inflammation
1.
de Aguiar Vallim TQ, Tarling EJ, Edwards PA: Pleiotropic roles of bile acids in metabolism. Cell Metab 2013;17:657-669.
2.
Russel DW: The enzymes, regulation and genetics of bile acid synthesis and metabolism. Annu Rev Biochem 2003;72:137-174.
3.
Dawson PA: Bile secretion and the enterohepatic circulation; in Feldman M, Friedman LS, Brandt LJ, Sleisenger MH (eds): Gastrointestinal and Liver Disease. Philadelphia, Saunders, 2010, vol 1, pp 1075-1088.
4.
Sung JY, Costerton JW, Shaffer EA: Defense system in the biliary tract against bacterial infection. Dig Dis Sci 1992;37:689-969.
5.
Wang DQ, Cohen DE, Carey MC: Biliary lipids and cholesterol gallstone disease. J Lipid Res 2000;50(suppl):S406-S411.
6.
Chandra R, Liddle RA: Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 2007;14:63-67.
7.
Chiang JY: Bile acids: regulation of synthesis. J Lipid Res 2009;50:1965-1966.
8.
Lamcharfi E, Cohen-Solal C, Parquet M, Lutton C, Dupré J, Meyer C: Determination of molecular associations of some hydrophobic and hydrophilic bile acids by infrared and Raman spectroscopy. Eur Biophys J 1997;25:285-291.
9.
Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, Nicholson JK, Holmes E: Systemic gut microbial modulation of bile acid modulation in host tissue compartments. Proc Natl Acad Sci USA 2011;108(suppl 1):4523-4530.
10.
Devkota S, Wang Y, Musch MW, Leone W, Fehlner-Peach, Nadimpali A, Antonopulos DA, Jabri B, Chang EB: Dietary fat-induced taurocholic acid promotes pathobiont expansion and colitis in II10-/-mice. Nature 2012;487:104-108.
11.
Fiorucci S, Cipriani S, Mencarelli A, Renga B, Distrutti E, Baldelli F: Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Curr Mol Med 2010;10:579-595.
12.
Keane RM, Gadacz TR, Munster AM, Birmingham W, Winchurch RA: Impairment of human lymphocyte function by bile salts. Surgery 1984;95:439-443.
13.
Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Gouma DJ: Inflammatory and immunologic effects of obstructive jaundice: pathogenesis and treatment. J Am Surg 1995;18:567-581.
14.
Drivas G, James O, Wardle N: Study of reticuloendothelial phagocyte capacity in patients with cholestasis. Brit Med J 1976;1:1568-1569.
15.
Calmus Y, Guechot J, Podevin P, Bonnefis MT, Giboudeau J, Poupon R: Differential effects of chemodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor alpha production by monocytes. Hepatology 1992;16:719-723.
16.
Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S: The bile acid receptor FXR is a modulator of intestinal innate immunity. J Immunol 2009;183:6251-6261.
17.
Renga B, Mencarelli A, Cipriani S, D'Amore C, Carino A, Bruno A, Francisci D, Zampella A, Distrutti E, Fiorucci S: The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation. PLoS One 2013;8:e54472.
18.
Wang YD, Chen WD, Wang M, Yu D, Forman BM, Huang W: Farnesoid X receptor antagonizes nuclear factor kappa B in hepatic inflammatory response. Hepatology 2008;48:1632-1643.
19.
Zhang S, Liu Q, Wang J, Harnish C: Suppression of interleukin 6 induced C reactive protein expression by FXR agonists. Biochem Biophys Res Commun 2009;379:476-479.
20.
Gadaleta RM, van Erpecum KJ, Oldenburg B, Willemsen EC, Renooli W, Mutilli S, Klomp LW, Siersema PD, Schipper ME, Danese S, Penna G, Laverny G, Adorini L, Moschetta A, van Mil SW: Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 2011;60:463-472.
21.
Mencarelli A, Renga B, Migliorati M, Cipriani S, Distrutti E, Santucci L, Fiorucci S: The bile acid sensor farnesoid receptor is a modulator of liver immunity in a rodent model of acute hepatitis. J Immunol 2009;183:6657-6666.
22.
Hanniman EA, Lambert G, McCarthy TC, Sinal CJ: Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E deficient mice. J Lipid Res 2005;46:2595-2604.
23.
Gadaleta RM, van Mil SWC, Oldenburg B, Siersema PD, Klomp LWJ, van Erpecum KJ: Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease. Biochim Biophys Acta 2010;1801:683-692.
24.
Zong L, Qu Y, Luo DX, Zhu ZY, Zhang S, Su Z, Shan JC, Gao XP, Lu LG: Preliminary experimental research on the mechanism of liver bile secretion stimulated by peppermint oil. J Dig Dis 2011;12:295-301.
25.
Keitel V, Donner M, Winandy S, Kubitz R, Haussinger D: Expression and function of bile acid receptor TGRT on Kupffer cells. Biophys Res Commun 2008;372:78-84.
26.
Stepanov V, Stankov K, Mikov M: The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders. J Recept Signal Transduct Res 2013;33:213-223.
27.
Haselow K, Bode JG, Wammers M, Ehlting C, Keitel V, Kleinebrecht L, Schupp AK, Haussinger D, Graf D: Bile acids PKA-dependently induce a switch of the IL-10/IL-12 ratio and reduce proinflammatory capability of human macrophages. J Leukoc Biol 2013;94:1253-1264.
28.
Pascucussi JM, Gerbal-Chaloin S, Pichard-Garcia L, Daujat M, Fabre JM, Maurel P, Vilarem MJ: Interleukin 6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem Biophys Res Commun 2000;274:707-713.
29.
Inoue K, Borchers CH, Negishi M: Cohesin protein 3MC1 represses the nuclear receptor CAR mediated synergistic activation of a human P450 gene by xenobiotics. Biochem J 2006;398:125-133.
30.
Ray A, Prefontaine KE: Physical association and functional antagonism between p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994;91:752-756.
31.
Pinette KV, Yee YK, Amegadzie BY, Nagpal S: Vitamin D receptor as a drug discovery target. Mini Rev Med Chem 2003;3:193-204.
32.
Gascon-Barré M, Demers C, Mirshani A, Néron S, Zalzal S, Nanci A: The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology 2003;35:126-131.
33.
Alrefai WA, Gill RK: Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res 2007;24:1803-1823.
34.
Ogura M, Nishida S, Ishikawa M, Sakurai K, Shimizu M, Matsuo S, Amano S, Uno S, Makishima M: Vitamin D3 modulates the expression of bile acid regulatory genes and represses inflammation in bile duct-ligated mice. J Pharmacol Exp Ther 2009;328:564-570.
35.
Needham BD, Trent MS: Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. Nat Rev Microbiol 2013;11:467-481.
36.
Szabo G, Bala S, Petrasek J, Gattu A: Gut-liver axis and sensing microbes. Dig Dis 2010;28:737-744.
37.
Nádházi Z, Takáts A, Offenmüller K, Bertók L: Plasma endotoxin level of healthy donors. Acta Microbiol Immunhol Hung 2002;49:151-157.
38.
Győrfy ZS, Duda E, Vizler CS: Interactions between LPS moieties and macrophage pattern recognition receptors. Vet Immunol Immunpathol 2013;152:28-36.
39.
Landy M, Pillemer L: Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides. J Exp Med 1956;103:823-830.
40.
Ulich TR, Guo K, del Castillo J: Endotoxin-induced cytokine gene expression in vivo. Expression of tumor necrosis factor mRNA in visceral organs under physiologic conditions and during endotoxinemia. Am J Pathol 1989;143:11-14.
41.
Morrison DC, Bucklin SE: Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental Gram-negative sepsis. Scand J Infect Dis Suppl 1996;101:3-8.
42.
Sipka S, Seres T, Dinya Z, Szekanecz Z, Szentmiklósi J, Bodolay E, Szegedi G: Tumour necrosis factor-α and adenosine in endotoxin shock-related cardiovascular symptoms. Mediators Inflamm 1995;4:454-455.
43.
Kelly CJ, Colgan SP, Frank DN: Of microbes and meals: the health consequences of dietary endotoxinemia. Nutr Clin Pract 2012;27:215-225.
44.
Blaut M, Klaus S: Intestinal microbiota and obesity. Handb Exp Pharmacol 2012;209:251-273.
45.
Teixeira TF, Collado MC, Ferreira CL, Bressan J, Peluzio MdoC: Potential mechanism for the emerging link between obesity and increased intestinal permeability. Nutr Res 2012;32:637-647.
46.
Kosters A, Karpen SJ: The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis 2010;30:186-194.
47.
Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D: Enteric bacteria, liopopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 2000;6:205-214.
48.
Sakisaka S, Koga H, Sasatomi K, Mimira Y, Kawaguchi T, Tanikawa K: Biliary secretion of endotoxin and pathogenesis of primary biliary cirrhosis. Yale J Biol Med 1997;70:403-406.
49.
Piya MK, Harte AL, McTernan PG: Metabolic endotoxaemia: is it more than just a gut feeling. Curr Opin Lipidol 2013;24:78-85.
50.
von Mutius E, Braun-Fahrlander C, Schierl R, Riedler J, Ehlermann S, Maisch S, Waser M, Nowak D: Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 2000;30:1230-1234.
51.
Gereda JE, Leung DY, Thatayatikom A, Streib JE, Price MR, Klinnert MD, Liu AH: Relation between house-dust endotoxin exposure type 1 T cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 2000;355:1680-1683.
52.
Natarajan S, Kim J, Bouchard J, Cruikshank W, Remick DG: Pulmonary endotoxin tolerance protects against cockroach allergen induced asthma-like inflammation in a mouse model. Int Arch Allergy Immunol 2012;158:120-130.
53.
Illi S, Depner M, Genuneit J, Horak E, Loss G, Strunz-Lehner C, Büchele G, Boznanski A, Danielewicz H, Cullinan P, Heederik D, Braun-Fahrlander C, von Mutius E: Protection from childhood asthma and allergy in Alpine farm environments - the GABRIEL Advanced Studies. J Allergy Clin Immunol 2012;129:1470-1477.
54.
Baumann S, Lorentz A: Obesity - a promoter of allergy? Int Arch Allergy Immunol 2013;162:205-213.
55.
Kocsár LT, Bertók L, Várterész V: Effect of bile acids on the intestinal absorption of endotoxin in rats. J Bacteriol 1969;100:220-223.
56.
Parlesak A, Schaeckeler S, Moser L, Bode C: Conjugated primary salts reduce permeability of endotoxin through intestinal epithelial cells and synergize with phosphatidylcholine in suppression of inflammatory cytokine production. Crit Care Med 2007;35:2367-2374.
57.
Fukuoka S, Richter W, Howe J, Andra J, Rössle M, Alexander C, Gutsmann T, Brandenburg K: Biophysical investigations into the interactions of endotoxins with bile acids. Innate Immun 2011;18:307-317.
58.
Bertók L: Bile acids in physico-chemical host defence. Pathophysiology 2004;11:139-145.
59.
Bertók L: Role of endotoxins and bile acids in the pathogenesis of septic circulatory shock. Acta Chir Hung 1997;36:33-36.
60.
Gyucsovics K, Bertók L: Pathophysiology of psoriasis: coping endotoxins with bile acid therapy. Pathophysiology 2003;10:57-61.
61.
Itoh S, Kono M, Akimoto T: Psoriasis treated with ursodeoxycholic acid: three case reports. Clin Exp Dermatol 2007;32:398-400.
62.
Dial E, Romero JJ, Villa X, Mercer DW, Lichtenberger LM: Lipopolysaccharide induced gastrointestinal injury in rats: role of surface hydrophobicity and bile salts. Shock 2002;17:77-80.
63.
Tlaskalova-Hogenova H, Steankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R, Kozakova H, Rossmann P, Bartova J, Sokol D, Funda DP, Borovska D, Rehakova Z, Sinkora J, Hofman J, Drastich P, Kokesova A: Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 2004;15:97-108.
64.
Hojo M, Sano N, Takikawa H: Effects of lipopolysaccharide on the biliary excretion of bile acids and organic anions in rats. J Gastroenterol Hepatol 2003;18:815-821.
65.
Huang CT, Rodriguez JT, Woodward WE, Nichols BL: Comparison of pattern of fecal bile acid and neutral sterol between children and adults. Am J Clin Nutr 1976;29:1196-1203.
66.
Gerhold K, Avagyan A, Reichert E, Blumchen K, Wahn U, Hamelmann E: Lipopolysaccharides modulate allergen specific immune regulation in a murine model of mucosal tolerance induction. Int Arch Allergy Immunol 2008;147:25-34.
67.
Brix S, Kjaer TM, Barkholt V, Frokiaer H: Lipopolysaccharide contamination of beta-lactoglobulin affects the immune response against intraperitoneally and orally administered antigen. Int Arch Allergy Immunol 2004;135:216-220.
68.
Gajhede M, Osmark P, Flemming M, Poulsen M, Ipsen H, Larsen JN, Joost van Neerven RJ, Schou C, Lowenstein H, Spangfort MD: X ray and NMR structure of Bet v 1, the origin of birch pollen allergy. Nat Struct Biol 1996;3:1040-1045.
69.
Markovic-Housley Z, Degano M, Lamba D, Roepenack-Lahaye E, Clemens S, Susani M, Ferreira F, Scheiner O, Breiteneder H: Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its likely biological function as a plant steroid carrier. J Mol Biol 2003;325:123-133.
70.
Barrasa JI, Olmo N, Lizarbe MA, Turnay J: Bile acids in the colon, from healthy to cytotoxic molecules. Toxicol In Vitro 2013;27:964-977.
71.
Bernstein H, Bernstein C, Payne CM, Dvorak K: Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gasroenterol 2009;15:3329-3340.
72.
Payne CM, Crowley-Skillicorn C, Bernstein C, Holubec H, Moyer MP, Bernstein H: Hydrophobic bile acid induced micronuclei formation, mitotic perturbations, and decreases in spindle checkpoint proteins: relevance to genomic instability in colon carcinogenesis. Nutr Cancer 2010;62:825-840.
73.
Koutsounas I, Patsouris E, Theocharis S: Pregnane X receptor and human malignancy. Histol Histopathol 2013;28:405-420.
74.
Bailey AM, Zhan L, Maru D, Shureigi I, Pickering CR, Kiriakova G, Izzo J, He N, Wei C, Baladandayuthapani V, Liang H, Kopetz S, Powis G, Guo GL: FXR silencing in human colon cancer by DNA methylation and KRAS signalling. Am J Physiol Gastrointest Liver Physiol 2014;306:G48-G58.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.